Image
Scientists discover how nicotine affects the pathway in the brain that controls appetite, a discovery that may lead to new obesity treatments and quitting tobacco without gaining weight.

Yale University researchers found a specific subclass of brain receptors which influences nicotine's ability in reducing appetite in rodents.

The lab study carried out on mice showed that a nicotine-like drug, cytisine, specifically activates nicotinic receptors in a part of brain known as hypothalamus that controls appetite.

The attachment of nicotinic molecules or any compound mimicking them to these receptors enhances the activity of pro-opiomelanocortin (POMC) neurons, which affects obesity in humans and animals.

"We found that nicotine reduced eating and body fat through receptors implicated in nicotine aversion and withdrawal rather than reward and reinforcement," said lead author Marina Picciotto, whose study was published in the journal Science.

"Many people say they won't quit smoking because they'll gain weight. Ultimately, we would like to help people maintain their body weight when they kick the habit and perhaps help non-smokers who are struggling with obesity," she added.

Moreover, the effect of smoking on appetite contributes to the deadly habit of smoking in some people especially young women despite its several proven health risks.

Scientists hope their findings may also lead to the development of safe and effective medications for controlling appetite and obesity.